[go: up one dir, main page]

YU64300A - Derivati 2"-deoksi higromicina - Google Patents

Derivati 2"-deoksi higromicina

Info

Publication number
YU64300A
YU64300A YU64300A YU64300A YU64300A YU 64300 A YU64300 A YU 64300A YU 64300 A YU64300 A YU 64300A YU 64300 A YU64300 A YU 64300A YU 64300 A YU64300 A YU 64300A
Authority
YU
Yugoslavia
Prior art keywords
compounds
formula
infections
relates
deoxy
Prior art date
Application number
YU64300A
Other languages
English (en)
Inventor
Robert Gerald Linde
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU64300A publication Critical patent/YU64300A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Ovaj pronalazak se odnosi na jedinjenja formule (1) i njihove farmaceutski prihvatljive soli, prolekove i solvate, gde su R1 i R2 definisani u opisu. Jedinjenja formule (1) su antibakterijska i antiprotozoa sredstva koja se mogu koristiti za tretiranje raznih bakterijskih i protozoa infekcija i poremećaja povezanih sa tim infekcijama. Ovaj pronalazak se odnosi na farmaceutske preparate koji sadrže jedinjenja formule (1) i na postupke tretiranja bakterijskih i protozoa infekcija preko ordiniranja jedinjenja formule (1).[This invention relates to compounds of formula (1) and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R1 and R2 are as defined herein. The compounds of formula (1) are antibacterial and antiprotozoal agents that may be used to treat various bacterial and protozoal infections and disorders related to such infections. The invention also relates to pharmaceutical compositions containing the compounds of formula (1) and to methods of treating bacterial and protozoal infections by administering the compounds of formula (1).
YU64300A 1998-05-04 1999-04-08 Derivati 2"-deoksi higromicina YU64300A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8405898P 1998-05-04 1998-05-04

Publications (1)

Publication Number Publication Date
YU64300A true YU64300A (sh) 2003-07-07

Family

ID=22182624

Family Applications (1)

Application Number Title Priority Date Filing Date
YU64300A YU64300A (sh) 1998-05-04 1999-04-08 Derivati 2"-deoksi higromicina

Country Status (38)

Country Link
US (1) US6342497B1 (sh)
EP (1) EP1077984B1 (sh)
JP (1) JP2002513798A (sh)
KR (1) KR100396099B1 (sh)
CN (1) CN1299367A (sh)
AP (1) AP1069A (sh)
AR (1) AR015776A1 (sh)
AT (1) ATE243218T1 (sh)
AU (1) AU762302B2 (sh)
BG (1) BG104995A (sh)
BR (1) BR9910232A (sh)
CA (1) CA2331261C (sh)
DE (1) DE69908936T2 (sh)
DK (1) DK1077984T3 (sh)
DZ (1) DZ2779A1 (sh)
EA (1) EA004374B1 (sh)
ES (1) ES2199559T3 (sh)
GT (1) GT199900058A (sh)
HN (1) HN1999000064A (sh)
HR (1) HRP20000748A2 (sh)
HU (1) HUP0102412A3 (sh)
ID (1) ID26368A (sh)
IL (1) IL139020A0 (sh)
IS (1) IS5680A (sh)
MA (1) MA26626A1 (sh)
NO (1) NO20005551L (sh)
NZ (1) NZ507450A (sh)
OA (1) OA11507A (sh)
PA (1) PA8471901A1 (sh)
PE (1) PE20000440A1 (sh)
PL (1) PL344085A1 (sh)
PT (1) PT1077984E (sh)
SK (1) SK16442000A3 (sh)
TN (1) TNSN99084A1 (sh)
TR (1) TR200003249T2 (sh)
WO (1) WO1999057127A1 (sh)
YU (1) YU64300A (sh)
ZA (1) ZA993063B (sh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20011904A3 (cs) * 1998-12-02 2001-10-17 Pfizer Products Inc. Deriváty hygromycinu jako antibakteriální činidla
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
EE200200671A (et) 2000-06-02 2004-08-16 Pfizer Products Inc. Hügromütsiin A derivaadid bakteriaalsete ja algloomadest põhjustatud infektsioonide ravimiseks
CN102168034B (zh) * 2010-11-29 2012-12-05 中国科学院南海海洋研究所 一种海洋链霉菌以及利用该菌制备替达霉素a和b的方法
EP3840743A4 (en) * 2018-08-20 2022-08-17 Northeastern University Hygromycin a compounds and methods of treating spirochete diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2832356B2 (ja) * 1988-03-31 1998-12-09 武田薬品工業株式会社 ハイグロマイシン類の合成中間体および製造法

Also Published As

Publication number Publication date
BG104995A (bg) 2001-07-31
AU762302B2 (en) 2003-06-19
JP2002513798A (ja) 2002-05-14
TNSN99084A1 (fr) 2005-11-10
CA2331261C (en) 2004-07-27
OA11507A (en) 2004-05-13
SK16442000A3 (sk) 2001-07-10
MA26626A1 (fr) 2004-12-20
BR9910232A (pt) 2001-01-09
DK1077984T3 (da) 2003-09-15
HN1999000064A (es) 2000-01-12
EA200001028A1 (ru) 2001-04-23
ID26368A (id) 2000-12-14
AR015776A1 (es) 2001-05-16
US6342497B1 (en) 2002-01-29
PA8471901A1 (es) 2000-09-29
IS5680A (is) 2000-10-24
GT199900058A (es) 2000-10-07
AU2850899A (en) 1999-11-23
NO20005551D0 (no) 2000-11-03
EA004374B1 (ru) 2004-04-29
ATE243218T1 (de) 2003-07-15
KR100396099B1 (ko) 2003-08-27
IL139020A0 (en) 2001-11-25
NZ507450A (en) 2003-08-29
HUP0102412A2 (hu) 2001-11-28
EP1077984B1 (en) 2003-06-18
EP1077984A1 (en) 2001-02-28
CA2331261A1 (en) 1999-11-11
PE20000440A1 (es) 2000-05-26
AP9901525A0 (en) 1999-06-30
AP1069A (en) 2002-05-14
NO20005551L (no) 2001-01-02
ES2199559T3 (es) 2004-02-16
DE69908936T2 (de) 2004-05-19
PL344085A1 (en) 2001-09-24
DZ2779A1 (fr) 2005-04-23
WO1999057127A1 (en) 1999-11-11
HRP20000748A2 (en) 2001-06-30
KR20010043267A (ko) 2001-05-25
PT1077984E (pt) 2003-09-30
CN1299367A (zh) 2001-06-13
HUP0102412A3 (en) 2003-07-28
TR200003249T2 (tr) 2001-03-21
DE69908936D1 (en) 2003-07-24
ZA993063B (en) 2000-11-03

Similar Documents

Publication Publication Date Title
AP2001002222A0 (en) Ketolide antibiotics.
CA2292359A1 (en) Novel azalides and methods of making same
UA70298A (uk) Похідні с-4"-заміщених макролідів, спосіб їх одержання, проміжні сполуки, фармацевтична композиція та спосіб лікування бактеріальної інфекції або протозойної інфекції
AU6484199A (en) Carbamate and carbazate ketolide antibiotics
AP2001002131A0 (en) Novel macrolide antibiotics.
PT1132392E (pt) Antibioticos cetolidos
YU66900A (sh) Derivati higromicina a
YU64300A (sh) Derivati 2"-deoksi higromicina
CA2351829A1 (en) Macrolide antibiotics
AP2001002154A0 (en) Hygromycin a derivatives (changed by the ISA to read hygromycin a derivatives as antibacterial agents.
MXPA02011966A (es) Derivados de higromicina a para el el tratamiento de infecciones bacterianas y por protozoarios.
AP2002002492A0 (en) Hygromycin a prodrugs.